Combined Evaluation of AFP, CA15-3, CA125, CA19-9, and CEA Tumor Markers in Patients with Hepatitis B and C

被引：0
|
作者：
Assmar, Mehdi [1 ]
Yeganeh, Sara [1 ]
Mansourghanaei, Fariborz [2 ]
Amirmozafari, Nour [3 ]
机构：
[1] Islamic Azad Univ, Dept Microbiol, Lahijan, Iran
[2] Guilan Univ Med Sci, Gastrointestinal & Liver Dis Res Ctr, Rasht, Iran
[3] Iran Univ Med Sci, Sch Med, Dept Microbiol, Tehran, Iran
来源：
IRANIAN JOURNAL OF PUBLIC HEALTH | 2016年 / 45卷 / 12期
关键词：
Tumor markers; Hepatitis B; Hepatitis C; ELISA; CLINICAL-IMPLICATIONS; ALPHA-FETOPROTEIN; LIVER-DISEASE; SERUM; CANCER; EPIDEMIOLOGY; PREVALENCE; INFECTION; ANTIGEN;
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
Background: This study aimed to determine the role of tumor markers AFP, CA15-3, CA125, CA19-9 and CEA in patients with hepatitis B and C. Methods: This descriptive cross-sectional study was performed from Oct 2012 to Oct 2014. Serum samples of 129 patients with hepatitis B and C referred to Guilan Liver and Digestive Disease Research Center in Rasht, Iran were collected and checked for the existence of the listed tumor markers by ELISA. Results: No increase in serum levels of tumor marker CA19-9, CEA and CA15-3 were seen in patients with hepatitis (P>0.05). In patients with hepatitis B, increase in CA125 were observed (P=0.03). In hepatitis C patients, there was an increase in AFP levels (P=0.03). Conclusion: The levels of AFP and CA125 markers were high in hepatitis C and hepatitis B, respectively. However, the increased levels were not seen is malignancy. Due to the small sample size, further study is necessary to find the reasons of the increase.
引用
收藏
页码：1645 / 1651
页数：7
相关论文
共 50 条
  • [1] Diagnostic role of tumour markers CEA, CA15-3, CA19-9 and CA125 in lung cancer
    Ghosh I.
    Bhattacharjee D.
    Das A.K.
    Chakrabarti G.
    Dasgupta A.
    Dey S.K.
    Indian Journal of Clinical Biochemistry, 2013, 28 (1) : 24 - 29
  • [2] The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer
    Wang, Weigang
    Xu, Xiaoqin
    Tian, Baoguo
    Wang, Yan
    Du, Lili
    Sun, Ting
    Shi, Yanchun
    Zhao, Xianwen
    Jing, Jiexian
    CLINICA CHIMICA ACTA, 2017, 470 : 51 - 55
  • [3] Clinical Performance of CEA, CA19-9, CA15-3, CA125 and AFP in Gastrointestinal Cancer Using LOCI™-based Assays
    Dolscheid-Pommerich, Ramona C.
    Manekeller, Steffen
    Walgenbach-Bruenagel, Gisela
    Kalff, Joerg C.
    Hartmann, Gunther
    Wagner, Birgit Stoffel
    Holdenrieder, Stefan
    ANTICANCER RESEARCH, 2017, 37 (01) : 353 - 359
  • [4] Clinical value of preoperative serum tumor markers CEA, CA19-9, CA125, and CA15-3 in surgically treated urachal cancer
    Stokkel, Laura E.
    van Rossum, Huub H.
    van de Kamp, Maaike W.
    Boellaard, Thierry N.
    Bekers, Elise M.
    Kok, Niels F. M.
    van Rhijn, Bas W. G.
    Mertens, Laura S.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (07) : 326.e17 - 326.e24
  • [5] CEA、AFP、CA125、CA15-3、CA19-9检测对恶性肿瘤的诊断价值探讨
    朱海龙
    现代医药卫生, 2006, (22) : 3422 - 3423
  • [6] The reference intervals for CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1
    Yang, Jingjing
    Tang, Aiguo
    Ma, Junfen
    Sun, Xiaoxu
    Ming, Liang
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2019, 79 (1-2): : 71 - 74
  • [7] 血清CEA、CA125、CA19-9、CA15-3在肺癌诊断中的价值
    廖渝
    蒋飞龙
    陈兴文
    放射免疫学杂志, 2008, 21 (06) : 603 - 604
  • [8] CEA、CA125、CA15-3、CA19-9检测对胃癌的诊断价值分析
    王园园
    现代诊断与治疗, 2021, 32 (07) : 1080 - 1081
  • [9] Comparison of tumor markers (CA19-9, CA15-3 and CA125) on ACS-180 (Bayer) and Immulite 2000 (DPC).
    Vieira, LA
    Pereima, I
    Medeiros, Y
    Raynauld, M
    Bertani, A
    Cargnin, F
    Zunino, J
    CLINICAL CHEMISTRY, 2002, 48 (06) : A24 - A24
  • [10] CEA、CA19-9、CA125和CA15-3联合检测用于恶性肿瘤诊断
    严桂风
    临床检验杂志, 1998, (06) : 54 - 55
12345